Abstract
A Corrigendum onTargeting myeloid checkpoint molecules in combination with antibody therapy: A novel anti-cancer strategy with IgA antibodies?
by Chan C, Lustig M, Baumann N, Valerius T, van Tetering G and Leusen JHW (2022) 13:932155. doi: 10.3389/fimmu.2022.932155
by Chan C, Lustig M, Baumann N, Valerius T, van Tetering G and Leusen JHW (2022) 13:932155. doi: 10.3389/fimmu.2022.932155
Original language | English |
---|---|
Article number | 1017924 |
Pages (from-to) | 1-2 |
Journal | Frontiers in Immunology |
Volume | 13 |
DOIs |
|
Publication status | Published - 13 Sept 2022 |
Keywords
- antibodies
- cancer immonotherapy
- CD47-SIRPalpha axis
- IgA
- immune checkpoint
- macrophages
- myeloid checkpoints
- neutrophils (PMNs)